Literature DB >> 11683254

Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population.

J Kotzan1, W Wade, H H Yu.   

Abstract

PURPOSE: The purpose of the study was to determine the incidence of GERD associated with prescription NSAID consumption.
METHODS: All Georgia Medicaid patients > 25 years of age and continuously eligible for 1996, 1997, and 1998 were included in the study. Patients were excluded if they received a GERD diagnoses during 1996 and 1997. Patients were observed in 1998 and classified into GERD and control cohorts. Comorbidities, demographics, and NSAID prescription consumption were retained and modeled with logistic regression.
RESULTS: The absolute risk of developing GERD without previous NSAID consumption was 0.38. The absolute risk of developing GERD for those patients who consumed one or more NSAID prescriptions during 1996 and 1997 was 0.80. Thus, the relative risk of GERD for NSAID patients was 2.11. GERD was significantly associated with one or more NSAID prescriptions (OR = 1.82), age (OR = 1.05 for 5 year range), gender (OR = 1.31 for females), asthma (OR = 3.24), obesity (OR = 2.77), hiatal hernia (OR = 4.17), tobacco use (OR = 2.56), and alcohol (OR = 1.83). The initial NSAID prescription was responsible for the greatest marginal increase in GERD.
CONCLUSIONS: Our study suggests that NSAIDs are associated with GERD especially for females, alcohol and tobacco users, and patients with asthma, hiatal hernia, or obesity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11683254     DOI: 10.1023/a:1013010616496

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  39 in total

1.  Risk factors for ulcerative reflux oesophagitis: a case-control study.

Authors:  P Ryan; D J Hetzel; D J Shearman; A J McMichael
Journal:  J Gastroenterol Hepatol       Date:  1995 May-Jun       Impact factor: 4.029

Review 2.  Gastro-oesophageal reflux disease and asthma.

Authors:  D Choy; R Leung
Journal:  Respirology       Date:  1997-09       Impact factor: 6.424

Review 3.  Gastro-oesophageal reflux and respiratory disorders in adults.

Authors:  J Goldman; J R Bennett
Journal:  Lancet       Date:  1988-08-27       Impact factor: 79.321

Review 4.  The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines.

Authors:  M B Fennerty; D Castell; A M Fendrick; M Halpern; D Johnson; P J Kahrilas; D Leiberman; J E Richter; R E Sampliner
Journal:  Arch Intern Med       Date:  1996-03-11

5.  Deleterious effects of prostaglandin E2 in reflux oesophagitis.

Authors:  G Morgan
Journal:  Med Hypotheses       Date:  1996-01       Impact factor: 1.538

6.  Associations between different forms of gastro-oesophageal reflux disease.

Authors:  H B el-Serag; A Sonnenberg
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

7.  Risk factors associated with symptoms of gastroesophageal reflux.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Am J Med       Date:  1999-06       Impact factor: 4.965

8.  Role of the lower esophageal sphincter and hiatal hernia in the pathogenesis of gastroesophageal reflux disease.

Authors:  M Fein; M P Ritter; T R DeMeester; S Oberg; J H Peters; J A Hagen; C G Bremner
Journal:  J Gastrointest Surg       Date:  1999 Jul-Aug       Impact factor: 3.452

9.  Adenocarcinoma of the esophagus: role of obesity and diet.

Authors:  L M Brown; C A Swanson; G Gridley; G M Swanson; J B Schoenberg; R S Greenberg; D T Silverman; L M Pottern; R B Hayes; A G Schwartz
Journal:  J Natl Cancer Inst       Date:  1995-01-18       Impact factor: 13.506

10.  Methodological aspects of evaluation of Quality of Life in upper gastrointestinal diseases.

Authors:  E Dimenäs
Journal:  Scand J Gastroenterol Suppl       Date:  1993
View more
  26 in total

Review 1.  Canadian Digestive Health Foundation Public Impact Series: gastroesophageal reflux disease in Canada: incidence, prevalence, and direct and indirect economic impact.

Authors:  Richard N Fedorak; Sander Veldhuyzen van Zanten; Ron Bridges
Journal:  Can J Gastroenterol       Date:  2010-07       Impact factor: 3.522

Review 2.  Epidemiology of gastro-oesophageal reflux disease: a systematic review.

Authors:  J Dent; H B El-Serag; M-A Wallander; S Johansson
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

3.  Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms.

Authors:  Douglas A Corley; Ai Kubo; Wei Zhao
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

Review 4.  Proton Pump Inhibitors in the Elderly, Balancing Risk and Benefit: an Age-Old Problem.

Authors:  Takeshi Kanno; Paul Moayyedi
Journal:  Curr Gastroenterol Rep       Date:  2019-12-05

5.  Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study).

Authors:  Núria Piqué; Marta Ponce; Vicente Garrigues; Luis Rodrigo; Félix Calvo; Carlos Martín de Argila; Fernando Borda; Antonio Naranjo; Javier Alcedo; María José Soria; Enrique Rey; Luis Bujanda; Javier P Gisbert; David Suarez; Xavier Calvet; Julio Ponce
Journal:  United European Gastroenterol J       Date:  2015-07-24       Impact factor: 4.623

6.  Gastroesophageal reflux disease symptoms: prevalence, sociodemographics and treatment patterns in the adult Israeli population.

Authors:  Menachem Moshkowitz; Noya Horowitz; Zamir Halpern; Erwin Santo
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

Review 7.  Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review.

Authors:  Hashem B El-Serag; Stephen Sweet; Christopher C Winchester; John Dent
Journal:  Gut       Date:  2013-07-13       Impact factor: 23.059

8.  Celiac disease, eosinophilic esophagitis and gastroesophageal reflux disease, an adult population-based study.

Authors:  Jonas F Ludvigsson; Pertti Aro; Marjorie M Walker; Michael Vieth; Lars Agréus; Nicholas J Talley; Joseph A Murray; Jukka Ronkainen
Journal:  Scand J Gastroenterol       Date:  2013-05-14       Impact factor: 2.423

9.  Diet, lifestyle and gender in gastro-esophageal reflux disease.

Authors:  Maria Pina Dore; Emmanouil Maragkoudakis; Ken Fraley; Antonietta Pedroni; Vincenza Tadeu; Giuseppe Realdi; David Y Graham; Giuseppe Delitala; Hoda M Malaty
Journal:  Dig Dis Sci       Date:  2007-11-22       Impact factor: 3.199

Review 10.  Review on novel concepts of columnar lined esophagus.

Authors:  Johannes Lenglinger; Stephanie Fischer See; Lukas Beller; Enrico P Cosentini; Reza Asari; Fritz Wrba; Martin Riegler; Sebastian F Schoppmann
Journal:  Wien Klin Wochenschr       Date:  2013-09-06       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.